Hospital Central Denia 03700, Partida Beniadlà, S/N. Dénia,
Spain
Research Article
Pancreatic Ductal Adenocarcinoma: Implications of Epigenetic Role Related the Src Pathway
Author(s): Padin-Iruegas ME, Eugenyeva E, Herranz-Carnero M, Aguín Losada S, Brozos Vázquez E, Abdullkader I, Antúnez JR, Ruibal-Morell A and López-López RPadin-Iruegas ME, Eugenyeva E, Herranz-Carnero M, Aguín Losada S, Brozos Vázquez E, Abdullkader I, Antúnez JR, Ruibal-Morell A and López-López R
Epigenetic has become, in recent years, in a very important process in the control of several pathologies, including cancer. DNA methylation has been described in numerous studies as crucial for differentiation control, cell proliferation and invasion in cancer. Pancreas ductal adenocarcinoma is one of the most deadly diseases of our society; its complexity and variability have become one of the medical challenges of this decade. Combining the potential of epigenetic with the high mortality and the limited knowledge of pancreatic ductal adenocarcinoma origin, may result in new approaches for diagnosis, treatment and monitoring, crucial in this pathology. For this purpose, we analyzed genes involved in different cellular processes (GSTP1, p16, RASFF1A, RARβ2, CyclinD2, HIN-1, SOCS1, TIMP3, DAPK and TWIST1) in 61 cases of pancreatic ductal adenocarcinom.. Read More»
DOI:
10.4172/1948-5956.1000247
Cancer Science & Therapy received 5332 citations as per Google Scholar report